Omada Health Inc. (OMDA)
NASDAQ: OMDAHealth CareMedical/Nursing ServicesUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
OMDA stock chart
Technical analysisKey statistics
All statistics- Market cap
- $736.39M
- P/E (TTM)
- 29.68
- Forward P/E
- 17.18
- EPS (TTM)
- $0.40
- Dividend yield
- None
- 52-week range
- 10.28 – 25.45
- Day range
- 11.76 – 12.64
- Volume / Avg
- 1.71M / 1.33M
- Beta
- —
- Shares outstanding
- 62.04M
52-week range
OMDA stock today
Shares of Omada Health (OMDA) finished lower on Nov 20 at $11.87, a drop of 5.04% or $0.63 per share, versus the S&P 500's 3.70% decline. Shares are 53.4% below their 52-week high of $25.45, set on Aug 27, 2026 and 15.5% above the 52-week low of $10.28, near the bottom of the past year's range. OMDA is down 24.8% year to date, underperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has lost 36.2%.
At 29.7x trailing earnings, Omada Health trades below the peer-group median of 47.6x. Its forward P/E of 17.2x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.
Summary generated from market data by MetaCap's automated system. Methodology
About Omada Health
Company profileOmada Health, Inc., together with its subsidiary, Physera, Inc., provides a range of virtual care programs in the United States. The company offers cardiometabolic programs for prediabetes, diabetes, and hypertension; a physical therapy program to address musculoskeletal conditions; other support programs for members taking glucagon-like peptide-1 agonists in its cardiometabolic program; and weight management programs, as well as various behavioral health support programs. It also delivers virtual care.
- Sector
- Health Care
- Industry
- Medical/Nursing Services
- CEO
- Mr. Sean P. Duffy
- Headquarters
- South San Francisco, CA
- Employees
- 980
- IPO year
- 2025
- Website
- omadahealth.com
Financial highlights
Full financialsIn fiscal 2025, Omada Health generated $260.2 million in revenue, up 53.2% from fiscal 2024, its 2nd consecutive year of revenue growth. Omada Health reported a net loss of $12.8 million, compared with a loss of $47.1 million a year earlier. Gross margin was 65.7% (up from 60.6%) and operating margin -4.6%.
| Fiscal year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Revenue | $260.21M | $169.80M | $122.78M |
| Growth | +53.24% | +38.29% | — |
| Net income | $-12.78M | $-47.14M | $-67.51M |
| EPS (diluted) | $-0.35 | $-6.11 | $-9.52 |
Analyst forecast
ForecastConsensus (12 analysts)
buy
Avg. price target
$26.50+123.25%
- Strong buy 5
- Buy 5
- Hold 2
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Earnings
Earnings history- Last reported (Sep/2026)
- Nov 5, 2026
- EPS actual vs est.
- $-0.03 vs $0.02
- Surprise
- -250.00%
OMDA news
All OMDA news- Omada Health Presents AI-Powered Meal Feedback Research and 12-Month GLP-1 Care Track Outcomes at ObesityWeek 2026GlobeNewswire
- Omada: 3 Key Takeaways for Long-Term InvestorsNasdaqOMDA, BF.A
- Omada Health (OMDA) Q3 2026 Earnings Call TranscriptNasdaq
- Omada Health Reports Third Quarter 2026 ResultsGlobeNewswire
- Charles River Laboratories (CRL) Tops Q3 Earnings and Revenue EstimatesNasdaqCRL, OMDA
- Omada Health to Present Peer-Reviewed Research on Improving Weight Loss and Body Composition During GLP-1 Treatment at World Obesity and Weight Management CongressGlobeNewswire
- Omada Health to Announce Third Quarter 2026 Financial Results and Host Conference Call on November 5, 2026GlobeNewswire
- Is Hinge Health Stock a Buy as Growth Accelerates and Risks Rise?NasdaqHNGE, TDOC, OMDA
Omada Health peers
Health Care sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| SBCSBC Medical Group Holdings Incorporated | 5.17 | -7.68% | $530.32M | vs OMDA |
| AHCOAdaptHealth Corp. | 7.20 | -0.69% | $982.98M | vs OMDA |
| SRTAStrata Critical Medical Inc. Class A | 4.56 | -5.59% | $407.30M | vs OMDA |
| PIIIP3 Health Partners Inc. Class A | 1.69 | -9.14% | $350.24M | vs OMDA |
| STLNStarling Oncology Inc. | 3.00 | -5.66% | $305.97M | vs OMDA |
| AUNAAuna SA Class A | 3.66 | -6.15% | $271.05M | vs OMDA |
| PNTGThe Pennant Group Inc. | 34.64 | +1.61% | $1.22B | vs OMDA |
| INNVInnovAge Holding Corp. | 9.16 | +2.81% | $1.25B | vs OMDA |
Indexes, lists and sector
Omada Health stock FAQ
What is Omada Health's stock price today?
OMDA last traded at $11.87 as of Nov 20, 4:00 PM EST, down 5.04% on the day. Prices are delayed at least 15 minutes.
What is OMDA's P/E ratio?
OMDA trades at a trailing P/E ratio of 29.68 and a forward P/E of 17.18, compared with a median of 47.6 for its closest peers.
Who is Omada Health's CEO?
Mr. Sean P. Duffy is the chief executive officer of Omada Health Inc., which has about 980 employees.
What is the OMDA 52-week high?
The 52-week high for OMDA is $25.45 and the 52-week low is $10.28. The stock is currently 53.4% below its high.